Insider sale
TAYSHA GENE THERAPIES, INC.
$234.5K
46.06K shares
What this filing means
MCAULIFFE SEAN plans to sell 46.06K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $234.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0001979693-26-000005
46.06K
Shares to sell
$234.5K
Approx. market value
46.06K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
1/23/2026
46.06KTotal acquired46.06K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 46.06K | — |
| Total | 46.06K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
46.06K
Market value
$234.5K
1/23/2026
Total
Units
46.06K
Value
$234.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/23/2026 | 46.06K | $234.5K | Nasdaq | Planned |
| Total | 46.06K | $234.5K | ||